{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:43:53Z","timestamp":1793213033317,"version":"4.5.0"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T00:00:00Z","timestamp":1701648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Autoimmune arthritis \u2013 such as rheumatoid arthritis \u2013 affect a significant proportion of the population, which can cause everyday joint pain, decreased mobility and reduced quality of life. Despite having more and more therapeutic options available, there are still a lot of patients who cannot reach remission or low disease activity by current therapies. This causes an urgent need for the development of new treatment options. The Syk tyrosine kinase plays an essential role in B cell receptor, Fc receptor and integrin signaling. It has been shown that the hematopoietic cell-specific deletion of Syk resulted in a complete protection against autoantibody-induced experimental arthritis. This prompted us to test the effect of entospletinib, a second generation, Syk-selective inhibitor, which has a tolerable safety profile according to hematological clinical trials, in experimental autoimmune arthritis. We found that entospletinib dose-dependently decreased the macroscopic signs of joint inflammation, while it did not affect the health status of the animals. In line with these findings, local neutrophil accumulation and cytokine levels were reduced compared to the vehicle-treated group, while macrophage accumulation and synovial fibroblast numbers were not significantly altered. Meanwhile, entospletinib dose-dependently decreased the cell responses of immune complex- or integrin ligand-activated neutrophils. Overall, we found that selective Syk inhibition by entospletinib reduced the activity of autoantibody-induced experimental arthritis, which seems to be based mainly on the effect of the inhibitor on neutrophil functions. Our data raise the possibility that entospletinib could be a good drug candidate in the treatment of human autoimmune arthritis.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1279155","type":"journal-article","created":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T05:05:38Z","timestamp":1701666338000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["The selective inhibition of the Syk tyrosine kinase ameliorates experimental autoimmune arthritis"],"prefix":"10.3389","volume":"14","author":[{"given":"Eszter","family":"K\u00e1poszt\u00e1s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Balogh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attila","family":"M\u00f3csai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9va","family":"Kemecsei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"Jakus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam\u00e1s","family":"N\u00e9meth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,12,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"18001","DOI":"10.1038\/nrdp.2018.1","article-title":"Rheumatoid arthritis","volume":"4","author":"Smolen","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217344","article-title":"EULAR definition of difficult-to-treat rheumatoid arthritis","volume":"80","author":"Nagy","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(02)00275-3","article-title":"Arthritis critically dependent on innate immune system players","volume":"16","author":"Ji","year":"2002","journal-title":"Immunity"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.174.6.3668","article-title":"Manifestations of inflammatory arthritis are critically dependent on LFA-1","volume":"174","author":"Watts","year":"2005","journal-title":"J Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/art.27238","article-title":"Neutrophils in a mouse model of autoantibody-mediated arthritis: critical producers of Fc receptor \u03b3, the receptor for C5a, and lymphocyte function-associated antigen 1","volume":"62","author":"Monach","year":"2010","journal-title":"Arthritis Rheum"},{"key":"B6","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/378298a0","article-title":"Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk","volume":"378","author":"Turner","year":"1995","journal-title":"Nature"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1084\/jem.186.7.1027","article-title":"A critical role for Syk in signal transduction and phagocytosis mediated by Fc\u03b3 receptors on macrophages","volume":"186","author":"Crowley","year":"1997","journal-title":"J Exp Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.18.7.4209","article-title":"The Syk protein tyrosine kinase is essential for Fc\u03b3 receptor signaling in macrophages and neutrophils","volume":"18","author":"Kiefer","year":"1998","journal-title":"Mol Cell Biol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/16.9.2333","article-title":"The Fc receptor \u03b3-chain and the tyrosine kinase Syk are essential for activation of mouse platelets by collagen","volume":"16","author":"Poole","year":"1997","journal-title":"EMBO J"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(02)00303-5","article-title":"Syk is required for integrin signaling in neutrophils","volume":"16","author":"M\u00f3csai","year":"2002","journal-title":"Immunity"},{"key":"B11","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1124\/jpet.106.109058","article-title":"R406, an orally available spleen tyrosine kinase inhibitor blocks Fc receptor signaling and reduces immune complex-mediated inflammation","volume":"319","author":"Braselmann","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1000500","article-title":"An oral spleen tyrosine kinase (Syk) inhibitor for rheumatoid arthritis","volume":"363","author":"Weinblatt","year":"2010","journal-title":"N Engl J Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.140238","article-title":"A phase III multicenter, randomized, double-blind, placebo-controlled, parallel-group study of 2 dosing regimens of fostamatinib in patients with rheumatoid arthritis with an inadequate response to a tumor necrosis factor-\u03b1 antagonist","volume":"41","author":"Genovese","year":"2014","journal-title":"J Rheumatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/art.38851","article-title":"Effects of fostamatinib, an oral spleen tyrosine kinase inhibitor, in rheumatoid arthritis patients with an inadequate response to methotrexate: results from a phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study","volume":"66","author":"Weinblatt","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.1990","article-title":"Comprehensive analysis of kinase inhibitor selectivity","volume":"29","author":"Davis","year":"2011","journal-title":"Nat Biotechnol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/art.27438","article-title":"Genetic deficiency of Syk protects mice from autoantibody-induced arthritis","volume":"62","author":"Jakus","year":"2010","journal-title":"Arthritis Rheum"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00555","article-title":"Lineage-specific analysis of Syk function in autoantibody-induced arthritis","volume":"9","author":"N\u00e9meth","year":"2018","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-08-595934","article-title":"An open-label phase 2 trial of entospletinib (GS-9973), a selective spleen tyrosine kinase inhibitor, in chronic lymphocytic leukemia","volume":"125","author":"Sharman","year":"2015","journal-title":"Blood"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2018.1562180","article-title":"Entospletinib monotherapy in patients with relapsed or refractory chronic lymphocytic leukemia previously treated with B-cell receptor inhibitors: results of a phase 2 study","volume":"60","author":"Awan","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00252","article-title":"Importance of Fc receptor \u03b3-chain ITAM tyrosines in neutrophil activation and in vivo autoimmune arthritis","volume":"10","author":"N\u00e9meth","year":"2019","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80045-x","article-title":"From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins","volume":"10","author":"Korganow","year":"1999","journal-title":"Immunity"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20081859","article-title":"Critical role of phospholipase C\u03b32 in integrin and Fc receptor-mediated neutrophil functions and the effector phase of autoimmune arthritis","volume":"206","author":"Jakus","year":"2009","journal-title":"J Exp Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1084\/jem.20132496","article-title":"The Src family kinases Hck, Fgr, and Lyn are critical for the generation of the in vivo inflammatory environment without a direct role in leukocyte recruitment","volume":"211","author":"Kov\u00e1cs","year":"2014","journal-title":"J Exp Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"11004","DOI":"10.1038\/ncomms11004","article-title":"Neutrophil-specific deletion of the CARD9 gene expression regulator suppresses autoantibody-induced","volume":"7","author":"N\u00e9meth","year":"2016","journal-title":"Nat Commun"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.1.618","article-title":"Critical but overlapping role of Fc\u03b3RIII and Fc\u03b3RIV in activation of murine neutrophils by immobilized immune complexes","volume":"180","author":"Jakus","year":"2008","journal-title":"J Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0904163","article-title":"Neutrophil functions and autoimmune arthritis in the absence of p190RhoGAP: Generation and analysis of a novel null mutation in mice","volume":"185","author":"N\u00e9meth","year":"2010","journal-title":"J Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.3.1601","article-title":"Essential role of neutrophils in the initiation and progression of a murine model of rheumatoid arthritis","volume":"167","author":"Wipke","year":"2001","journal-title":"J Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1701803","article-title":"Myeloid-specific deletion of Mcl-1 yields severely neutropenic mice which survive and breed in homozygous form","volume":"201","author":"Csepregi","year":"2018","journal-title":"J Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200526167","article-title":"A crucial role for macrophages in the pathology of K\/BxN serum-induced arthritis","volume":"35","author":"Solomon","year":"2005","journal-title":"Eur J Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1126\/science.1137306","article-title":"Cadherin-11 in synovial lining formation and pathology in arthritis","volume":"315","author":"Lee","year":"2007","journal-title":"Science"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1263-7","article-title":"Distinct fibroblast subsets drive inflammation and damage in arthritis","volume":"570","author":"Croft","year":"2019","journal-title":"Nature"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.3449","article-title":"Second-generation SYK inhibitor entospletinib ameliorates fully established inflammation and bone destruction in the cherubism mouse model","volume":"33","author":"Yoshimoto","year":"2018","journal-title":"J Bone Miner Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.122430","article-title":"SYK inhibitor entospletinib prevents ocular and skin GVHD in mice","volume":"3","author":"Poe","year":"2018","journal-title":"JCI Insight"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.05.017","article-title":"The Syk tyrosine kinase is required for skin inflammation in an in vivo mouse model of epidermolysis bullosa acquisita","volume":"137","author":"N\u00e9meth","year":"2017","journal-title":"J Invest Dermatol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2016.04.002","article-title":"Feedback amplification of neutrophil function","volume":"37","author":"N\u00e9meth","year":"2016","journal-title":"Trends Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N Engl J Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1279155\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T05:05:40Z","timestamp":1701666340000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1279155\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,4]]},"references-count":36,"alternative-id":["10.3389\/fimmu.2023.1279155"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1279155","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,4]]},"article-number":"1279155"}}